These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28713070)

  • 21. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
    Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
    Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
    Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
    Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
    Asaad NY; Abd El-Wahed MM; Dawoud MM
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
    Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
    Moreau EJ; Matutes E; A'Hern RP; Morilla AM; Morilla RM; Owusu-Ankomah KA; Seon BK; Catovsky D
    Am J Clin Pathol; 1997 Oct; 108(4):378-82. PubMed ID: 9322589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymphoma and chronic lymphocytic leukemia using flow cytometry.
    Myles N; Giri P; Chim I; Kodituwakku A
    Leuk Lymphoma; 2021 Feb; 62(2):504-506. PubMed ID: 31559884
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD43 in chronic lymphoproliferative leukemias.
    Sorigue M; Juncà J; Sarrate E; Grau J
    Cytometry B Clin Cytom; 2018 Jan; 94(1):136-142. PubMed ID: 28073173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD200 expression in B-cell chronic lymphoproliferative disorders.
    El Desoukey NA; Afify RA; Amin DG; Mohammed RF
    J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
    Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
    Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24039011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
    Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
    Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
    Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunophenotype analysis of leukemic mantle cell lymphoma].
    Zhao M; Wu YJ; Fan L; Qiu HR; Yang H; Zhang ZH; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):371-6. PubMed ID: 23628035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
    Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
    Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of a scoring system for diagnosis of chronic lymphocytic leukemia in Thai patients.
    Promsuwicha O; Songmuang W; Auewarakul CU
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S232-8. PubMed ID: 21721452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.
    Alapat D; Coviello-Malle J; Owens R; Qu P; Barlogie B; Shaughnessy JD; Lorsbach RB
    Am J Clin Pathol; 2012 Jan; 137(1):93-100. PubMed ID: 22180482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.